Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (25,033,674)	$ (8,502,410)
Unrealized loss on marketable securities	(726)
Comprehensive net loss	(25,034,400)	$ (8,502,410)
Adjustments to reconcile net loss to net cash:
Depreciation and amortization	3,549	18,062
Bad debt	1,704	32,813
Stock and stock option compensation and deferred consulting	$ 2,709,290	1,760,621
Inducement of warrant exchange		650,616
Amortization of discounts and financing fees	$ 40,000	429,731
Change in fair value of derivative liabilities	$ (1,155,784)	1,680,246
Expense on issuance of derivative liabilities		604,504
Property and equipment expensed as research and development		177,652
Loss on retirement of assets		$ 37,543
Dividend series A convertible preferred stock	$ 233,657
Unrealized other comprehensive loss	726
Loss on impairment	21,654,507
(Increase) decrease in operating assets:
Accounts receivable	$ (426)	$ 9,959
Inventory		1,335,306
Prepaid expenses and other assets	$ (4,353)	(104,903)
Increase (decrease) in operating liabilities:
Accounts payable	(203,948)	$ 140,044
Accrued expenses	243,112
Related party advances	(8,154)
Total adjustments	23,513,880	$ 6,772,195
Net Cash Used in Operating Activities	(1,520,520)	$ (1,730,215)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(1,517)
Purchase of intellectual property	(3,630)	$ (17,585)
Net Cash Used in Investing Activities	(5,147)	$ (17,585)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of conversion rights from a shareholder	(25,000)
Proceeds from Series B convertible preferred stock	$ 1,600,000
Proceeds from Loan		$ 1,835,000
Repayments of notes payable	$ (20,000)	$ (125,000)
Proceeds from issuance of stock
Proceeds from warrant exercise		$ 14,691
Net Cash Provided By Financing Activities	$ 1,555,000	1,724,691
Net increase (decrease) in cash and cash equivalents	29,333	(23,109)
Cash and cash equivalents, beginning of period	203	29,430
Cash and cash equivalents, end of period	$ 115,729	$ 6,321
Supplemental Cash Flow Information:
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:
Series C Convertible Preferred stock issued in merger	10,790,367
Beneficial conversion features on Series B convertible preferred stock	$ 281,000
Net assets acquired in merger	$ 146,667
Common stock issued for convertible notes payable and accrued interest		$ 252,272
Transfers from derivative liability to additional paid in capital	$ 74,681	3,098,549
Discount on debt recorded as derivative liability		$ 1,275,309